Home GPCR & G Protein Angiotensin Receptor

Angiotensin Receptor

Other GPCR & G Protein Related Inhibitors

Hedgehog/Smoothened PKA CGRP Receptor Endothelin Receptor S1P Receptor Cannabinoid Receptor SGLT Opioid Receptor GPR CCR
Cat.No. Product Name Information Product Use Citations Product Validations
S5067 Losartan Losartan(DuP-753) is a selective, orally administered, nonpeptide blocker of angiotensin II type 1 (AT1) receptor used to treat high blood pressure, diabetic kidney disease, heart failure, and left ventricular enlargement.
Sci Rep, 2025, 15(1):12955
Sci Adv, 2025, 11(23):eadu2695
Eur J Med Res, 2024, 29(1):109
S1578 Candesartan Candesartan is an angiotensin II receptor antagonist with IC50 of 0.26 nM.
bioRxiv, July 13, 2023, 548707
J Immunother Cancer, 2024, 12(11)e009805
Front Pharmacol, 2022, 13:828643
Verified customer review of Candesartan
S1359 Losartan Potassium (DuP 753) Losartan Potassium is an angiotensin II receptor antagonist, competes with the binding of angiotensin II to AT1 receptors with IC50 of 20 nM.
J Immunother Cancer, 2024, 12(11)e009805
Commun Biol, 2024, 7(1):1581
Pflügers Archiv - European Journal of Physiology, 2024, 1677-1691
Verified customer review of Losartan Potassium (DuP 753)
S1738 Telmisartan Telmisartan (BIBR 277) is an angiotensin II receptor antagonist (ARB) used in the management of hypertension.
Bioorganic Chemistry, June 28, 2024, 107602
Anticancer Research, December 2021, 6179-6190
Sci Rep, 2025, 15(1):22112
Verified customer review of Telmisartan
S7098 PD123319 PD 123319 is a potent, selective AT2 angiotensin II receptor antagonist with IC50 of 34 nM.
Journal for ImmunoTherapy of Cancer, September 12, 2018, 88
Molecular Medicine Reports, April 15, 2019, 4553-4560
Anticancer Research, 2024, 5263-5270
Verified customer review of PD123319
S1894 Valsartan Valsartan is a selective angiotensin II receptor antagonist, used to treat high blood pressure and congestive heart failure.
Cell Death Discovery, December 29, 2025, Not specified
Cell Death Discovery, December 29, 2025, Online ahead of print
Anticancer Research, December 2021, 6179-6190
Verified customer review of Valsartan
S1507 Irbesartan Irbesartan is a highly potent and specific angiotensin II type 1 (AT1) receptor antagonist with IC50 of 1.3 nM.
J Immunother Cancer, 2024, 12(11)e009805
bioRxiv, 2023, 2023.07.12.548707
Xenobiotica, 2020, 10.1080/00498254.2020.1745318
Verified customer review of Irbesartan
S2037 Candesartan Cilexetil Candesartan Cilexetil (TCV-116) is an angiotensin II receptor antagonist with IC50 of 0.26 nM, used in the treatment of hypertension.
bioRxiv, 2025, 2025.05.14.654016
J Immunother Cancer, 2024, 12(11)e009805
Int J Mol Sci, 2022, 23(20)12326
Verified customer review of Candesartan Cilexetil
S1604 Olmesartan Medoxomil Olmesartan Medoxomil (CS-866,RNH-6270) is a selective angiotensin II type 1 (AT(1)) receptor antagonist, used in the treatment of high blood pressure.
J Immunother Cancer, 2024, 12(11)e009805
American Journal of Physiology-Cell Physiology, 2024, C1067-C1079
Frontiers in Pharmacology, 2022, 837756
Verified customer review of Olmesartan Medoxomil
S3046 Azilsartan Azilsartan (TAK-536) is an angiotensin II type 1 (AT1) receptor antagonist with IC50 of 2.6 nM.
J Immunother Cancer, 2024, 12(11)e009805
Frontiers in Pharmacology, 2021, 774709
Front Pharmacol, 2021, 12:774709
Verified customer review of Azilsartan